Alessandro Corso
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 86
- Multiple Myeloma Research and Treatments 76
- Acute Myeloid Leukemia Research 9
- Oncology 49
- Cancer Treatment and Pharmacology 27
- Peptidase Inhibition and Analysis 9
- Co-authors
- Mario LazzarinoSilvia MangiacavalliMarzia VarettoniPatrizia ZappasodiMeletios Α. DimopoulosH. Miles PrinceMarta OlesnyckyjZhinuan Yu
- Journals
- Blood (20 papers)Annals of Hematology (11 papers)Cancer (5 papers)British Journal of Haematology (4 papers)Leukemia Research (4 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Alessandro Corso
108 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Hematology 2.4k
- Genetics 718
- Oncology 1.6k
- Molecular Biology 1.7k
- Pathology and Forensic Medicine 410
Countries citing papers authored by Alessandro Corso
This map shows the geographic impact of Alessandro Corso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Corso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Corso more than expected).
Fields of papers citing papers by Alessandro Corso
This network shows the impact of papers produced by Alessandro Corso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Corso. The network helps show where Alessandro Corso may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alessandro Corso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 15 | |
| 4 | 2020 | 7 | |
| 5 | 2017 | 60 | |
| 6 | 2017 | 6 | |
| 7 | 2016 | 37 | |
| 8 | HEALTH RESOURCE UTILIZATION WITH CONTINUOUS LENALIDOMIDE TREATMENT (TX) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) | 2015 | 1 |
| 9 | 2012 | 7 | |
| 10 | 2011 | 31 | |
| 11 | 2011 | 8 | |
| 12 | 2010 | 14 | |
| 13 | 2009 | 12 | |
| 14 | 2007 | 85 | |
| 15 | 2007 | 6 | |
| 16 | Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma Hit paper breakdown → | 2007 | 1073 |
| 17 | 2004 | 58 | |
| 18 | The irreplaceable image. Thalidomide in refractory myeloma patients: early changes in bone marrow cellularity. | 2001 | 1 |
| 19 | Thalidomide in refractory myeloma patients: Early changes in bone marrow cellularity | 2001 | 2 |
| 20 | 2001 | 2 |
About Alessandro Corso
Alessandro Corso is a scholar working on Hematology, Oncology, Genetics, Pathology and Forensic Medicine and Molecular Biology, having authored 114 papers that have together received 3.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (76 papers), Cancer Treatment and Pharmacology (27 papers), Protein Degradation and Inhibitors (22 papers), Lymphoma Diagnosis and Treatment (10 papers), Peptidase Inhibition and Analysis (9 papers), Acute Myeloid Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). The work is most often cited by research in Hematology (2.4k citations), Genetics (718 citations), Oncology (1.6k citations), Molecular Biology (1.7k citations) and Pathology and Forensic Medicine (410 citations). Alessandro Corso has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Mario Lazzarino, Silvia Mangiacavalli, Marzia Varettoni, Patrizia Zappasodi, Meletios Α. Dimopoulos, H. Miles Prince, Marta Olesnyckyj, Zhinuan Yu, Robert Knight and Gian-Matteo Pica. Their work appears in journals such as Blood, Annals of Hematology, Cancer, British Journal of Haematology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.